ARTICLE | Company News
Atox Bio, U.S. Department of Health and Human Services infectious news
June 20, 2016 7:00 AM UTC
HHS’s Biomedical Advanced Research and Development Authority (BARDA) exercised an option under a 2014 contract with Atox to develop AB103 to treat necrotizing soft tissue infections. The option bring...